ProMIS Neurosciences Statistics
Total Valuation
PMN has a market cap or net worth of $16.49 million. The enterprise value is $7.46 million.
Important Dates
The last earnings date was Monday, May 12, 2025, before market open.
Earnings Date | May 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
PMN has 32.69 million shares outstanding. The number of shares has increased by 97.91% in one year.
Current Share Class | 32.69M |
Shares Outstanding | 32.69M |
Shares Change (YoY) | +97.91% |
Shares Change (QoQ) | +0.09% |
Owned by Insiders (%) | 24.84% |
Owned by Institutions (%) | 8.00% |
Float | 17.66M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.66 |
P/TBV Ratio | 1.67 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.36
Current Ratio | 3.36 |
Quick Ratio | 2.07 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -19.56% and return on invested capital (ROIC) is -223.99%.
Return on Equity (ROE) | -19.56% |
Return on Assets (ROA) | -124.39% |
Return on Invested Capital (ROIC) | -223.99% |
Return on Capital Employed (ROCE) | -178.42% |
Revenue Per Employee | n/a |
Profits Per Employee | -$116,743 |
Employee Count | 8 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.26% in the last 52 weeks. The beta is 0.02, so PMN's price volatility has been lower than the market average.
Beta (5Y) | 0.02 |
52-Week Price Change | -68.26% |
50-Day Moving Average | 0.59 |
200-Day Moving Average | 0.91 |
Relative Strength Index (RSI) | 43.48 |
Average Volume (20 Days) | 56,030 |
Short Selling Information
The latest short interest is 139,360, so 0.43% of the outstanding shares have been sold short.
Short Interest | 139,360 |
Short Previous Month | 226,778 |
Short % of Shares Out | 0.43% |
Short % of Float | 0.79% |
Short Ratio (days to cover) | 5.92 |
Income Statement
Revenue | n/a |
Gross Profit | -10.64M |
Operating Income | -17.11M |
Pretax Income | -12.20M |
Net Income | -933,942 |
EBITDA | n/a |
EBIT | -17.11M |
Earnings Per Share (EPS) | -$0.03 |
Full Income Statement Balance Sheet
The company has $8.40 million in cash and n/a in debt, giving a net cash position of $8.40 million or $0.26 per share.
Cash & Cash Equivalents | 8.40M |
Total Debt | n/a |
Net Cash | 8.40M |
Net Cash Per Share | $0.26 |
Equity (Book Value) | 9.47M |
Book Value Per Share | 0.29 |
Working Capital | 9.59M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -21.82M |
Capital Expenditures | n/a |
Free Cash Flow | -21.82M |
FCF Per Share | -$0.67 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
PMN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -97.91% |
Shareholder Yield | -97.91% |
Earnings Yield | -5.89% |
FCF Yield | -137.61% |
Analyst Forecast
The average price target for PMN is $4.50, which is 791.80% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $4.50 |
Price Target Difference | 791.80% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on June 28, 2022. It was a reverse split with a ratio of 0.0166667:1.
Last Split Date | Jun 28, 2022 |
Split Type | Reverse |
Split Ratio | 0.0166667:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |